Mody Girish M, Patel Neeta, Budhoo Amritha, Dubula Thozama
Department of Rheumatology, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Department of Rheumatology, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Semin Arthritis Rheum. 2014 Oct;44(2):186-94. doi: 10.1016/j.semarthrit.2014.05.009. Epub 2014 May 9.
To determine the effect of systemic lupus erythematosus (SLE) and human immunodeficiency virus (HIV) infection on the course of each other and to review the published reports on concomitant SLE and HIV infection.
We performed a retrospective review of the records of patients with SLE and HIV seen in the Department of Rheumatology at the Inkosi Albert Luthuli Central Hospital, Durban, South Africa. We used the terms "systemic lupus erythematosus" and "HIV" or "AIDS" to identify patients with SLE and HIV infection reported in the English medical literature.
We identified 13 patients with SLE and HIV infection. All the patients were females and there were 11 African blacks and 2 Indians. SLE and HIV infection were diagnosed together in 6 patients. In this group, there were 5 lupus flares in 4 patients, and 2 of the flares followed highly active anti-retroviral treatment (HAART). Five patients developed HIV after the diagnosis of SLE. The 3 patients in whom follow-up data was available had inactive SLE, one of whom was on HAART. Two HIV-positive patients developed SLE after receiving HAART for 30 and 35 mo. Seven of our patients also had tuberculosis. Our literature search identified 58 previously reported patients with HIV and SLE.
Our case series and review of the literature show that there is a reduction in SLE disease activity in patients with concomitant SLE and HIV. However, when lupus flares occur in HIV-positive patients, they are unrelated to the use of HAART.
确定系统性红斑狼疮(SLE)和人类免疫缺陷病毒(HIV)感染对彼此病程的影响,并回顾已发表的关于SLE与HIV合并感染的报告。
我们对南非德班因科西·阿尔伯特·卢图利中央医院风湿病科诊治的SLE和HIV患者的病历进行了回顾性研究。我们使用“系统性红斑狼疮”和“HIV”或“艾滋病”等术语来识别英文医学文献中报道的SLE和HIV感染患者。
我们识别出13例SLE和HIV感染患者。所有患者均为女性,其中11例为非洲黑人,2例为印度人。6例患者同时诊断出SLE和HIV感染。在这组患者中,4例患者出现了5次狼疮发作,其中2次发作发生在高效抗逆转录病毒治疗(HAART)后。5例患者在诊断出SLE后感染了HIV。有3例患者可获得随访数据,其SLE病情处于非活动期,其中1例正在接受HAART治疗。2例HIV阳性患者在接受HAART治疗30个月和35个月后患上了SLE。我们的7例患者还患有结核病。我们的文献检索发现了58例先前报道的HIV和SLE患者。
我们的病例系列及文献回顾表明,SLE与HIV合并感染的患者中SLE疾病活动度有所降低。然而,HIV阳性患者出现狼疮发作时,与HAART的使用无关。